Anna S Berghoff

Anna S Berghoff

UNVERIFIED PROFILE

Are you Anna S Berghoff?   Register this Author

Register author
Anna S Berghoff

Anna S Berghoff

Publications by authors named "Anna S Berghoff"

Are you Anna S Berghoff?   Register this Author

68Publications

1001Reads

43Profile Views

Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?

Nat Rev Neurol 2019 Jun;15(6):314-315

Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41582-019-0178-0DOI Listing
June 2019

The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study.

Palliat Support Care 2019 02 24;17(1):82-86. Epub 2018 May 24.

Department of Biotechnological and Applied Clinical Sciences,University of L'Aquila,L'Aquila,Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1478951518000238DOI Listing
February 2019

PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome.

Histopathology 2018 Oct 4;73(4):573-584. Epub 2018 Jul 4.

Department of Otorhinolaryngology, Head and Neck Surgery, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13646DOI Listing
October 2018

Role of the blood-brain barrier in metastatic disease of the central nervous system.

Handb Clin Neurol 2018 ;149:57-66

Clinical Division of Oncology, Department of Medicine and CNS Tumors Unit, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-12-811161-1.00004-9DOI Listing
July 2018

New developments in brain metastases.

Ther Adv Neurol Disord 2018 28;11:1756286418785502. Epub 2018 Jun 28.

Department of Medicine I and Comprehensive Cancer Center CNS Unit (CCC-CNS), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756286418785502DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048670PMC
June 2018

Toward Precision Medicine in Brain Metastases.

Semin Neurol 2018 02 16;38(1):95-103. Epub 2018 Mar 16.

Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1627469DOI Listing
February 2018

Anti-angiogenic therapies in brain metastases.

Memo 2018 2;11(1):14-17. Epub 2018 Feb 2.

Department of Medicine I and Comprehensive Cancer Center Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-018-0384-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862919PMC
February 2018

Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM score.

Neuro Oncol 2017 Sep;19(9):1255-1262

Department of Medicine I, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland; Biostatistics Division, German Cancer Research Center, Heidelberg, Germany; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria; Department of Radiotherapy, Medical University of Vienna, Vienna, Austria; Department of Pathology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570252PMC
September 2017

CECOG educational illustrations: the blood-brain barrier and its relevance for targeted cancer therapies and immuno-oncology.

ESMO Open 2017 8;2(2):e000194. Epub 2017 Jun 8.

Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2017-000194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519816PMC
June 2017

Targeted Therapies for Melanoma Brain Metastases.

Curr Treat Options Neurol 2017 Apr;19(4):13

Department of Medicine I and Comprehensive Cancer Center CNS Unit (CCC-CNS), Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11940-017-0449-2
Publisher Site
http://dx.doi.org/10.1007/s11940-017-0449-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378732PMC
April 2017

Educational video: the role of PD-L1 in the local tumour microenvironment.

ESMO Open 2016 1;1(6):e000137. Epub 2017 Feb 1.

Central European Cooperative Oncology Group (CECOG), Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548971PMC
February 2017

Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment.

Am Soc Clin Oncol Educ Book 2016 ;35:e116-22

From the German Cancer Research Center, University of Heidelberg, Heidelberg, Germany; Department of Medicine I, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center Vienna CNS Unit, Vienna, Austria; Division of Hematology and Oncology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA; Burkhardt Brain Tumor and Neuro-Oncology Center, Neurologic Institute, Cleveland Clinic, Cleveland, OH; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_100005DOI Listing
January 2017

Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases.

Clin Cancer Res 2016 Dec 12;22(24):6078-6087. Epub 2016 Aug 12.

Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1327DOI Listing
December 2016

In search of a target: PD-1 and PD-L1 profiling across glioma types.

Neuro Oncol 2016 10 17;18(10):1331-2. Epub 2016 Aug 17.

Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria (A.S.B., M.P.); Comprehensive Cancer Center CNS Unit (CCC-CNS), Medical University of Vienna, Vienna, Austria (A.S.B., M.P.); Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany (A.S.B.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035530PMC
October 2016

Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?

Clin Neuropathol 2015 Nov-Dec;34(6):313-21

Department of Medicine I and Comprehensive Cancer Center CNS Unit, Medical University of Vienna, Vienna, Austria, Neurology Clinic, Heidelberg University Medical Center and Neurooncology Program, National Center for Tumor Diseases Heidelberg, Heidelberg, Germany, and Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766797PMC
September 2016

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions.

Clin Neuropathol 2015 Sep-Oct;34(5):250-7

Institute of Neurology, Medical University of Vienna, Vienna, Austria, Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland, Department of Medicine I, Comprehensive Cancer Center-CNS Tumours Unit (CCC-CNS), and Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542181PMC
July 2016

Psyche at the end of life: Psychiatric symptoms are prevalent in patients admitted to a palliative care unit.

Palliat Support Care 2016 06 8;14(3):250-8. Epub 2015 Oct 8.

Department of Psychiatry and Psychotherapy,Medical University of Vienna,Vienna,Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1478951515000899DOI Listing
June 2016

The future of targeted therapies for brain metastases.

Future Oncol 2015 ;11(16):2315-27

Department for Medicine I, Comprehensive Cancer Center Central Nervous System Unit (CCC-CNS), Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.127DOI Listing
May 2016

Cancer immune cycle: a video introduction to the interaction between cancer and the immune system.

ESMO Open 2016 12;1(3):e000056. Epub 2016 Apr 12.

Central European Cooperative Oncology Group (CECOG) , Vienna , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070358PMC
April 2016

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers.

ESMO Open 2016 16;1(2):e000024. Epub 2016 Mar 16.

Department of Medicine I, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2015-000024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070252PMC
March 2016

Evaluation of tyrosine kinase receptors in brain metastases of clear cell renal cell carcinoma reveals cMet as a negative prognostic factor.

Histopathology 2015 Dec 7;67(6):799-805. Epub 2015 Jun 7.

Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/his.12709
Publisher Site
http://dx.doi.org/10.1111/his.12709DOI Listing
December 2015

Assessing MGMT methylation status and its current impact on treatment in glioblastoma.

CNS Oncol 2015 ;4(1):47-52

Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns.14.50DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093023PMC
September 2015

Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.

Eur J Cancer 2015 Sep 8;51(13):1803-11. Epub 2015 Jul 8.

Department of Pathology, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Central Nervous System Unit (CCC-CNS), Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.06.107DOI Listing
September 2015

Atypical sporadic CJD-MM phenotype with white matter kuru plaques associated with intranuclear inclusion body and argyrophilic grain disease.

Neuropathology 2015 Aug 18;35(4):336-42. Epub 2015 Mar 18.

Institute of Neurology and Austrian Reference Center for Human Prion Diseases, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/neup.12192
Publisher Site
http://dx.doi.org/10.1111/neup.12192DOI Listing
August 2015

Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.

Eur J Haematol 2015 Jul 23;95(1):75-82. Epub 2015 Mar 23.

Unit for Bone Marrow and Stem Cell Transplantation, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12482DOI Listing
July 2015

Breast cancer brain metastases responding to lapatinib plus capecitabine as second-line primary systemic therapy.

Anticancer Drugs 2015 Jun;26(5):579-81

aComprehensive Cancer Center Departments of bMedicine 1, Clinical Division of Oncology cPathology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000217DOI Listing
June 2015

The inflammatory microenvironment in brain metastases: potential treatment target?

Chin Clin Oncol 2015 Jun;4(2):21

Department of Medicine I, Comprehensive Cancer Center Central, Nervous System Unit (CCC-CNS), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2015.06.03DOI Listing
June 2015

Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases.

Oncoimmunology 2016;5(1):e1057388. Epub 2015 Jun 9.

Department for Medicine I/Clinical Division of Oncology; Medical University of Vienna; Vienna, Austria; Comprehensive Cancer Center - CNS Tumors Unit; Medical University of Vienna; Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1057388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760339PMC
June 2015

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

Neuropathol Appl Neurobiol 2015 Feb;41(2):e41-55

Institute of Neurology, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center CNS Tumors Unit, Medical University of Vienna, Vienna, Austria; Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nan.12185DOI Listing
February 2015

Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer.

Histopathology 2014 Nov 5;65(5):684-92. Epub 2014 Aug 5.

Department of Internal Medicine 1, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, CNS Unit, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12475DOI Listing
November 2014

Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.

Breast 2014 Oct 10;23(5):637-43. Epub 2014 Jul 10.

Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria; Department of Pathology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2014.06.011DOI Listing
October 2014

Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study.

Clin Neuropathol 2014 Sep-Oct;33(5):329-34

Institute of Neurology, Medical University of Vienna, Vienna, Austria, AJ Roboscreen GmbH, Leipzig, Germany, Department of Neurology, present address: Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria, and Neurobiologie, CMRR, Hospices Civils de Lyon, Université Lyon, Lyon, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151342PMC
October 2014

Alleviation of brain edema and restoration of functional independence by bevacizumab in brain-metastatic breast cancer: a case report.

Breast Care (Basel) 2014 May;9(2):134-6

Department of Medicine I, Medical University of Vienna, Austria ; Comprehensive Cancer Center, CNS Tumors Unit (CCC-CNS), Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000360930DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038309PMC
May 2014

Clinical Neuropathology practice news 1-2014: pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma.

Clin Neuropathol 2014 Jan-Feb;33(1):6-14

Department of Medicine I, Medical University of Vienna, Vienna, Division of Pathology, Medical University of Innsbruck, Innsbruck, Comprehensive Cancer Center - CNS Tumors Unit (CCC-CNS), Medical University of Vienna, Vienna, Molecular Diagnostics, Austrian Institute of Technology, Department of Radiotherapy, Department of Neurosurgery, and Institute of Neurology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891253PMC
April 2014

Breast cancer brain metastases responding to primary systemic therapy with T-DM1.

J Neurooncol 2014 Jan 25;116(1):205-6. Epub 2013 Sep 25.

Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-013-1257-5DOI Listing
January 2014

High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.

Lung Cancer 2014 Jan 17;83(1):83-9. Epub 2013 Oct 17.

Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center Vienna, Central Nervous System Tumours Unit (CCC-CNS), Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.10.004DOI Listing
January 2014

Invasion patterns in brain metastases of solid cancers.

Neuro Oncol 2013 Dec 30;15(12):1664-72. Epub 2013 Sep 30.

Corresponding Author: Matthias Preusser, MD, Department of Medicine I and Comprehensive Cancer Center, Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829586PMC
December 2013

High-grade meningiomas: new avenues for drug treatment?

Curr Opin Neurol 2013 Dec;26(6):708-15

aDepartment of Medicine I & Comprehensive Cancer Center - CNS Unit, Medical University of Vienna bDepartment of Clinical Neurosciences, CHUV, Lausanne University Medical Center and University of Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/WCO.0000000000000035DOI Listing
December 2013

Biology in prevention and treatment of brain metastases.

Expert Rev Anticancer Ther 2013 Nov;13(11):1339-48

Department of Medicine I and Comprehensive Cancer Center CNS Unit (CCC-CNS), Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2013.852067DOI Listing
November 2013

No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibody.

Appl Immunohistochem Mol Morphol 2013 Oct;21(5):426-30

Departments of *Medicine I ¶Surgery ‡Institute of Neurology #Clinical Institute of Pathology †Comprehensive Cancer Center-Gastro-Esophageal Cancers Unit (CCC-GET), Medical University of Vienna §Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University ∥Clinical Cooperation Unit Neuropathology, DKFZ, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0b013e31827ce693DOI Listing
October 2013

Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancer.

Breast J 2013 Mar-Apr;19(2):149-55. Epub 2013 Jan 27.

Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/tbj.12070
Publisher Site
http://dx.doi.org/10.1111/tbj.12070DOI Listing
September 2013

Lack of BRAF V600E protein expression in primary central nervous system lymphoma.

Appl Immunohistochem Mol Morphol 2013 Jul;21(4):351-3

Department of Neuropathology, Institute of Neurology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0b013e3182688e59DOI Listing
July 2013

High plasma-GFAP levels in metastatic myxopapillary ependymoma.

J Neurooncol 2013 Jul 29;113(3):359-63. Epub 2013 Apr 29.

Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-013-1134-2DOI Listing
July 2013

Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers.

Clin Neuropathol 2013 May-Jun;32(3):148-58

Institute of Neurology, Department of Neurosurgery, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663466PMC
June 2013

Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients--yes, but how?

Clin Neuropathol 2012 Nov-Dec;31(6):405-8

Institute of Neurology, Department of Medicine I, Medical University of Vienna, and Comprehensive Cancer Center Vienna - CNS Tumors Unit, Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663470PMC
April 2013

Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapies.

Anticancer Res 2013 Mar;33(3):1065-71

Medical University of Vienna, Department of Surgery, Waehringer Guertel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
March 2013

Optimal management of brain metastases from breast cancer. Issues and considerations.

CNS Drugs 2013 Feb;27(2):121-34

Department of Medicine I, Clinical Division of Oncology, Comprehensive Cancer Centre, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40263-012-0024-zDOI Listing
February 2013

Brain metastasis: opportunity for drug development?

Curr Opin Neurol 2012 Dec;25(6):786-94

Department of Medicine I and Comprehensive Cancer Center CNS Unit, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0b013e328359320dDOI Listing
December 2012